Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified. more
| Time Frame | WDNA | S&P500 |
|---|---|---|
| 1-Week Return | -1.8% | -0.56% |
| 1-Month Return | 20.24% | 0.56% |
| 3-Month Return | 33.03% | 0.29% |
| 6-Month Return | 29.14% | 10.93% |
| 1-Year Return | 63.53% | 18.95% |
| 3-Year Return | 42.33% | 69.6% |
| 5-Year Return | -15.98% | 68.04% |
| 10-Year Return | -6.04% | 249.49% |
| Time Frame | WDNA | S&P500 |
|---|---|---|
| 1-Week Return | -61.21% | -25.38% |
| 1-Month Return | 841.74% | 7.03% |
| 3-Month Return | 218.19% | 1.18% |
| 6-Month Return | 67.96% | 23.41% |
| 1-Year Return | 63.53% | 18.95% |
| 3-Year Return | 12.49% | 19.25% |
| 5-Year Return | -3.42% | 10.94% |
| 10-Year Return | -0.62% | 13.33% |
| Stock name | Ticker | Weight |
|---|---|---|
Moderna Inc
|
MRNA |
7.37%
|
Twist Bioscience Corp
|
TWST |
7.37%
|
Eli Lilly & Co
|
LLY |
3.59%
|
Johnson & Johnson
|
JNJ |
2.82%
|
Immunome Inc
|
IMNM |
2.64%
|
10X Genomics Inc-Class A
|
TXG |
2.62%
|
Natera Inc
|
NTRA |
2.52%
|
Tempus Ai Inc
|
TEM |
2.27%
|
United Therapeutics Corp
|
UTHR |
2.1%
|
Darling Ingredients Inc
|
DAR |
2.05%
|
Stoke Therapeutics Inc
|
STOK |
1.83%
|
Corteva Inc
|
CTVA |
1.77%
|
Crispr Therapeutics Ag
|
CRSP |
1.69%
|
Revolution Medicines Inc
|
RVMD |
1.69%
|
Thermo Fisher Scientific Inc
|
TMO |
1.69%
|
Structure Therapeutics Inc
|
GPCR |
1.68%
|
Amgen Inc
|
AMGN |
1.67%
|
Krystal Biotech Inc
|
KRYS |
1.66%
|
Beam Therapeutics Inc
|
BEAM |
1.61%
|
Gilead Sciences Inc
|
GILD |
1.57%
|
Roivant Sciences Ltd
|
ROIV |
1.53%
|
Bunge Global Sa
|
2318605D |
1.47%
|
Novozymes A/S
|
NZYM.B.CO |
1.42%
|
Astrazeneca Plc
|
AZN.L |
1.42%
|
Pfizer Inc
|
PFE |
1.41%
|
Bayer AG
|
BAYN.DE |
1.41%
|
Arrowhead Pharmaceuticals Inc
|
ARWR |
1.39%
|
Iovance Biotherapeutics Inc
|
IOVA |
1.34%
|
Vertex Pharmaceuticals Inc
|
VRTX |
1.33%
|
Isis Pharmaceuticals Inc
|
ISIS |
1.29%
|
Biohaven Ltd
|
BHVN |
1.29%
|
Agios Pharmaceuticals Inc
|
AGIO |
1.28%
|
Uniqure NV
|
QURE |
1.17%
|
ABSCI Corp
|
ABSI |
1.16%
|
Novartis AG
|
NOVN.SW |
1.16%
|
Arcturus Therapeutics Hlgs
|
ARCT |
1.13%
|
Cullinan Therapeutics Inc
|
CGEM |
1.12%
|
Protagonist Therapeutics Inc
|
PTGX |
1.08%
|
Dyne Therapeutics Inc
|
DYN |
1.01%
|
Veracyte Inc
|
VCYT |
0.97%
|
Exelixis Inc
|
EXEL |
0.94%
|
Argenx Se - Adr
|
ARGX |
0.92%
|
Celldex Therapeutics Inc
|
CLDX |
0.91%
|
Biontech Se-ADR
|
BNTX |
0.87%
|
Repligen Corp
|
RGEN |
0.85%
|
Cg Oncology Inc
|
CGON |
0.85%
|
Editas Medicine Inc
|
EDIT |
0.84%
|
Halozyme Therapeutics Inc
|
HALO |
0.78%
|
Danaher Corp
|
DHR |
0.77%
|
Biogen Idec Inc
|
BIIB |
0.74%
|
Allogene Therapeutics Inc
|
ALLO |
0.72%
|
Merck & Co Inc/NJ
|
MRK |
0.72%
|
Syensqo Sa
|
SYENS.BR |
0.69%
|
Viking Therapeutics Inc
|
VKTX |
0.68%
|
Regenxbio Inc
|
RGNX |
0.68%
|
Sana Biotechnology Inc
|
SANA |
0.67%
|
Verbio AG
|
VBK.DE |
0.64%
|
Regeneron Pharmaceuticals Inc
|
REGN |
0.62%
|
Illumina Inc
|
ILMN |
0.58%
|
Insmed Inc
|
INSM |
0.57%
|
Nufarm Ltd/Australia
|
NUF.AX |
0.53%
|
Oxford Nanopore Technologies
|
ONT.L |
0.52%
|
FMC Corp
|
FMC |
0.51%
|
Green Plains Inc
|
GPRE |
0.5%
|
Genmab A/S -Sp ADR
|
GMAB |
0.46%
|
BioMarin Pharmaceutical Inc
|
BMRN |
0.45%
|
Techne Corp
|
TECH |
0.44%
|
Bridgebio Pharma Inc
|
BBIO |
0.44%
|
Ultragenyx Pharmaceutical Inc
|
RARE |
0.42%
|
Intellia Therapeutics Inc
|
NTLA |
0.36%
|
Genus Plc
|
GNS.L |
0.35%
|
Zoetis Inc
|
ZTS |
0.35%
|
Geron Corp
|
GERN |
0.34%
|
Sarepta Therapeutics Inc
|
SRPT |
0.3%
|
Rocket Pharmaceuticals Inc
|
RCKT |
0.3%
|
Tyson Foods Inc
|
TSN |
0.26%
|
QIAGEN N.V.
|
QIAGEN.N.V. |
0.25%
|
Alnylam Pharmaceuticals Inc
|
ALNY |
0.21%
|
Pacific Biosciences Of Calif
|
PACB |
0.21%
|
DREYFUS TRSY OBLIG CASH MGMT CL INS
|
DREYFUS.TRSY.OBLIG.CASH.MGMT.CL.INS |
0.08%
|
US DOLLAR
|
US.DOLLAR |
0.06%
|
DANISH KRONE
|
DANISH.KRONE |
0%
|
AUSTRALIAN DOLLAR
|
AUSTRALIAN.DOLLAR |
0%
|
EURO
|
EURO |
0%
|
SWISS FRANC
|
SWISS.FRANC |
0%
|
GREAT BRITISH POUND
|
GREAT.BRITISH.POUND |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
90.53% |
|
Materials
|
5.81% |
|
Consumer staples
|
3.59% |
|
Financials
|
0.07% |
WisdomTree BioRevolution Fund (WDNA) share price today is $23.47.
Yes, Indians can buy shares of WisdomTree BioRevolution Fund (WDNA) on Vested. To buy WDNA from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of WisdomTree BioRevolution Fund (WDNA) on Vested. You can start investing in WisdomTree BioRevolution Fund (WDNA) with a minimum investment of $1.
The 52-week high price of WisdomTree BioRevolution Fund (WDNA) is $24.2. The 52-week low price of WisdomTree BioRevolution Fund (WDNA) is $13.7.
The stock symbol (or ticker) of WisdomTree BioRevolution Fund is WDNA.
Yes, you can setup SIP in WisdomTree BioRevolution Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of WDNA on the Vested app.
The expense ratio of WisdomTree BioRevolution Fund (WDNA) is 0.45%.
Link copied